Screener
Xeris Biopharma Holdings, Inc. XERS Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
FAQ
- What is Xeris Biopharma Holdings, Inc.'s gross margin?
- Xeris Biopharma Holdings, Inc. (XERS) reported gross margin of 86.6% in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s gross margin changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s gross margin increased by 5.3% year-over-year, from 82.2% to 86.6%.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s gross margin?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s gross margin has grown at a 4.0% compound annual growth rate (CAGR), from 73.1% to 85.4%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Xeris Biopharma Holdings, Inc.'s gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude